Immutep Ltd (IMMP)
2.79
+0.10
(+3.72%)
USD |
NASDAQ |
May 03, 12:44
Immutep Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 02, 2024 | 249.73M |
| May 01, 2024 | 239.03M |
| April 30, 2024 | 249.73M |
| April 29, 2024 | 247.36M |
| April 26, 2024 | 244.98M |
| April 25, 2024 | 239.03M |
| April 24, 2024 | 237.85M |
| April 23, 2024 | 228.33M |
| April 22, 2024 | 205.75M |
| April 19, 2024 | 197.42M |
| April 18, 2024 | 191.48M |
| April 17, 2024 | 198.61M |
| April 16, 2024 | 198.61M |
| April 15, 2024 | 204.56M |
| April 12, 2024 | 225.96M |
| April 11, 2024 | 230.71M |
| April 10, 2024 | 230.71M |
| April 09, 2024 | 247.36M |
| April 08, 2024 | 260.43M |
| April 05, 2024 | 262.81M |
| April 04, 2024 | 258.06M |
| April 03, 2024 | 229.52M |
| April 02, 2024 | 231.90M |
| April 01, 2024 | 221.20M |
| March 28, 2024 | 206.94M |
| Date | Value |
|---|---|
| March 27, 2024 | 214.07M |
| March 26, 2024 | 214.07M |
| March 25, 2024 | 227.15M |
| March 22, 2024 | 223.58M |
| March 21, 2024 | 228.33M |
| March 20, 2024 | 220.01M |
| March 19, 2024 | 217.64M |
| March 18, 2024 | 217.64M |
| March 15, 2024 | 214.07M |
| March 14, 2024 | 229.52M |
| March 13, 2024 | 240.22M |
| March 12, 2024 | 233.09M |
| March 11, 2024 | 233.09M |
| March 08, 2024 | 256.87M |
| March 07, 2024 | 273.51M |
| March 06, 2024 | 254.49M |
| March 05, 2024 | 240.22M |
| March 04, 2024 | 209.31M |
| March 01, 2024 | 203.37M |
| February 29, 2024 | 208.12M |
| February 28, 2024 | 200.99M |
| February 27, 2024 | 206.94M |
| February 26, 2024 | 198.61M |
| February 23, 2024 | 196.24M |
| February 22, 2024 | 200.99M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
17.85M
Minimum
Apr 03 2020
322.25M
Maximum
Nov 05 2021
134.74M
Average
133.54M
Median
Jan 13 2023
Enterprise Value Benchmarks
| Opthea Ltd | 118.00M |
| Kazia Therapeutics Ltd | 5.265M |
| Bionomics Ltd | 0.576M |
| Alterity Therapeutics Ltd | -- |
| Mesoblast Ltd | -- |